Section
This qualitative study identifies key factors influencing the design, implementation, and sustainability of community-based adult eye screening programs in the U.S., highlighting challenges and opportunities for equitable, scalable vision s
Strabismus surgery effectively corrects hypertropia in sagging eye syndrome (SES), yet about 25% of patients experience delayed recurrent hypertropia over two years, reflecting SES’s progressive nature. Overcorrections are rare and ma
Advanced ultra-widefield OCT mapping elucidates spatial differences in foveal and optic nerve head positioning within posterior staphyloma of pathologic myopia, highlighting distinct remodeling processes and associations with axial length a
This review synthesizes evidence on PRN aflibercept treatment after complete polypoidal regression in PCV, highlighting recurrence rates, visual outcomes, and potential OCT biomarkers guiding individualized management.
The Phase 3 LYNX-1 trial demonstrates that 0.75% phentolamine ophthalmic solution improves mesopic low-contrast visual acuity and reduces photic symptoms in patients with dim light vision disturbances, including those post-keratorefractive
This longitudinal study shows that retinal microvascular changes measured by OCTA correspond with cerebral small vessel disease progression and cognitive decline in mild ischemic stroke patients, highlighting OCTA’s potential as a non
This study elucidates the unique East Asian-specific genetic variants and clinical progression of USH2A-associated retinitis pigmentosa in Koreans, highlighting the potential for exon 13-targeted treatments.
This review synthesizes current evidence on the frequency and risk factors of cystoid macular edema (CME) after cultured human corneal endothelial cell (cHCEC) injection, highlighting prostaglandin analog use as a key associated factor and
This prospective study demonstrates that WaveLight Plus InnovEyes ray-tracing-guided LASIK achieves excellent safety, efficacy, and astigmatic correction precision in treating myopia and myopic astigmatism over one year.
Fenofibrate use in type 2 diabetes patients is associated with a significant reduction in the risk of sight-threatening diabetic retinopathy compared to statins, based on UK primary care data over 12 years.
Intravitreal pegcetacoplan significantly slowed geographic atrophy progression by 41% over two years, maintaining efficacy in clinical practice for AMD patients, with stable visual acuity decline and manageable safety.
This retrospective cohort study compares visual field progression after repeat trabeculectomy versus Ahmed glaucoma valve implantation in eyes with prior trabeculectomy failure, revealing similar postoperative visual outcomes but greater in
A novel, cumulative risk factor approach identifies patients at increased risk for additional retinal intervention after laser retinopexy for retinal tears, improving surveillance and management strategies.
A large retrospective cohort study suggests that cetirizine, ibuprofen, and prednisone use in adults with type 2 diabetes is associated with significantly reduced incidence of diabetic macular edema and proliferative diabetic retinopathy, h
This study reveals significant shifts in the bacterial spectrum, antimicrobial resistance, and clinical presentation of acute postcataract endophthalmitis over 23 years, underscoring the need for updated surveillance and tailored treatment
A case series delineating a novel EFEMP1 variant, p.Arg140Trp, associated with late-onset peripheral retinal degeneration distinct from classic DHRD/ML, highlighting rod dysfunction precedes structural changes.
This article examines the critical need for refined clinical metrics in thyroid eye disease (TED) to better evaluate new targeted therapies, highlighting the Innovate TED Initiative’s efforts to develop and validate comprehensive outcome me
This study elucidates how ribbon-type reticular pseudodrusen, especially when coexisting with soft drusen, significantly impair retinal sensitivity in intermediate AMD, highlighting the importance of lesion phenotype in functional risk asse
This study reveals that 30.7% of atopic dermatitis patients treated with dupilumab develop ocular surface disease, despite prevalent ocular symptoms at baseline and increased ophthalmic treatment during therapy, linked to reduced conjunctiv
Phase 3 trials show satralizumab significantly improves proptosis, inflammation, and diplopia in thyroid eye disease with a favorable safety profile, marking a new therapeutic option targeting the IL-6 receptor pathway.
